AstraZeneca/MedImmune Versão em português


The São Paulo Research Foundation (FAPESP) and AstraZeneca/MedImmune signed a cooperation agreement with the purpose of establish the conditions for selection and funding of scientific and technological research involving collaboration between scientists working in public or private research or teaching institutions in the State of São Paulo and/or scientists from the AZ Brasil or MedImmune and its Affiliates.

The research will be selected through publicly announced calls for research proposals,

Cooperation agreement - Signed on March 13, 2015 and valid for five years.

Research projects selected in joint calls with FAPESP

Page updated on 04/05/2024 - Published on 03/18/2015